Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

IDX/LABS stock hub

IDX/LABS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IDX/LABSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

636B

Indonesia Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IDX/LABS

In the news

Latest news · IDX/LABS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.4P50 14.4P75 23.9

Trailing P/E52.7

P25 11.5P50 23.8P75 52.6

ROE8.2

P25 0.6P50 5.1P75 12.2

ROIC9.1

P25 1.3P50 6P75 11.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IDX/LABS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

178

Groups with data

Currency

IDR

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Indonesia
Country code	ID
Employees	54
Employees Change	-8%
Employees Change Percent	-12.9
Enterprise value	IDR 644.4B
Exchange	Indonesia Stock Exchange
Financial currency	IDR
First seen	2026-05-10
Industry	Medical Devices
Isin	ID1000205305
Last refreshed	2026-05-10
Market cap	IDR 636B
Price	IDR 161
Price currency	IDR
Rev Per Employee	3,812,115,872.52x
Sector	Healthcare
Sic	5047
Symbol	idx/LABS
Website	https://www.ubcindonesia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.9%
EV Earnings	53.4x
EV/EBIT	35.57x
EV/EBITDA	20.79x
EV/FCF	-32,726.99x
EV/Sales	3.13x
FCF yield	-0%
P/B ratio	4.16x
P/E ratio	52.7x
P/S ratio	3.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.8%
EBITDA Margin	14.94%
Gross margin	40.03%
Gross Profit	IDR 82.4B
Gross Profit Growth	42.81%
Gross Profit Growth Q	20.91%
Net Income	IDR 12.1B
Net Income Growth	211.6%
Net Income Growth Q	-77.84%
Net Income Growth Quarters	4%
Net Income Growth Years	2%
Pretax Margin	7.81%
Profit Margin	5.86%
Profit Per Employee	IDR 223.5M
Profitable Years	5
ROA	5.26
ROCE	11.61
ROE	8.22
ROIC	9.06
Roic5y	5.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	29.86%
EPS Growth	211.6
EPS Growth Q	-77.84
EPS Growth Quarters	4
EPS Growth Years	2
Revenue Growth	35.11x
Revenue Growth Q	19.6x
Revenue Growth Quarters	4x
Revenue Growth Years	3x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	IDR 0.96
Assets	IDR 218.6B
Cash	IDR 18.4B
Current Assets	IDR 172.1B
Current Liabilities	IDR 62.6B
Debt	IDR 26.8B
Debt EBITDA	IDR 0.87
Debt Equity	IDR 0.18
Debt FCF	IDR -1,363
Equity	IDR 152.9B
Interest Coverage	16.6
Liabilities	IDR 65.7B
Long Term Assets	IDR 46.5B
Long Term Liabilities	IDR 3.1B
Net Cash	IDR -8.4B
Net Cash By Market Cap	IDR -1.32
Net Debt EBITDA	IDR 0.27
Net Debt Equity	IDR 0.06
Tangible Book Value	IDR 149.2B
Tangible Book Value Per Share	IDR 37.78

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.75
Inventory Turnover	1.61
Net Working Capital	IDR 116.6B
Quick ratio	0.98
Working Capital	IDR 109.5B
Working Capital Turnover	IDR 1.86

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	29.84%
200-day SMA	143.4
50-day SMA	153.2
50-day SMA vs 200-day SMA	50over200
All Time High	228
All Time High Change	-29.39%
All Time High Date	2024-07-12
All Time Low	107
All Time Low Change	50.47%
All Time Low Date	2025-02-24
ATR	4.66
Beta1y	0.44
Beta2y	0.61
Ch YTD	17.52
High	172
High52	172
High52 Date	2026-05-08
High52ch	-6.4%
Low	151
Low52	120
Low52 Date	2025-07-30
Low52ch	34.17%
Ma50ch	5.11%
Price vs 200-day SMA	12.29%
RSI	63.77
RSI Monthly	59.71
RSI Weekly	61.91
Sharpe ratio	1.18x
Sortino ratio	2.14
Tr YTD	17.52
Tr1m	1.26%
Tr1w	8.78%
Tr3m	14.18%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	IDR 18.1B
Operating Income Growth	70.77
Operating Income Growth Q	-72.73
Operating margin	8.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	960,571,600%
Net Borrowing	-10,598,775,120
Shares Insiders	3.29%
Shares Out	3,950,000,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	IDR -19.7M
Average Volume	1,584,890x
Bv Per Share	38.7
CAPEX	IDR -16.7B
Ch1m	1.26
Ch1w	8.78
Ch1y	29.84
Ch3m	14.18
Ch6m	12.59
Change	6.62%
Change From Open	6.62
Close	151
Days Gap	0
Depreciation Amortization	12,638,895,494
Dollar Volume	2,576,483,000
Earnings Date	2026-04-24
EBIT	IDR 18.1B
EBITDA	IDR 30.8B
EPS	IDR 3.06
F Score	6
FCF	IDR -19.7M
FCF EV Yield	-0x
FCF Per Share	IDR -0
Financing CF	-10,598,775,119
Fiscal Year End	December
Founded	2,014
Graham Number	51.57898
Graham Upside	-67.96
Income Tax	IDR 4B
Investing CF	-16,717,928,825
Is Primary Listing	1
Last Earnings Date	2025-10-28
Last Report Date	2026-03-31
Ma150	145.2
Ma150ch	10.89%
Ma20	154.3
Ma20ch	4.34%
Net CF	-10,652,583,507
Open	151
P OCF Ratio	38.16
Position In Range	47.62
Ppne	33,151,187,942
Price Date	2026-05-08
Price EBITDA	IDR 20.68
Ptbv Ratio	4.26
Relative Volume	10.75x
Revenue	205,854,257,116x
Tax By Revenue	1.95x
Tax Rate	24.97%
Tr6m	12.59%
Volume	16,003,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IDX/LABS pay a dividend?

Capital-return profile for this ticker.

Performance

IDX/LABS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IDX/LABS?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+3.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

IDX/LABS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.8

Neutral momentum band

Price vs 200-day MA

+12.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.18

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IDX/LABS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current idx/LABS stock rating?

idx/LABS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full idx/LABS analysis?

The full report lives at /stocks/idx/LABS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for idx/LABS?

The latest report frames idx/LABS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the idx/LABS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.